The discovering comes as a part of a large-scale examine into Covid-19 reinfection after observations from healthcare professionals that the phenomenon was comparatively uncommon.
Oxford University Professor David Eyre, one of many authors of the examine, referred to as the findings “really good news”.
“We can be confident that, at least in the short term, most people who get Covid-19 won’t get it again,” he stated.
The authors highlighted they’d not but gathered sufficient information to make a judgement on reinfection after six months.
However, the continued examine has an finish objective of verifying how lengthy safety from reinfection lasts in complete.
The director of an infection prevention and management at examine companions Oxford University Hospitals (OUH), Katie Jeffery, referred to as the discovering “exciting”.
It indicated “that infection with the virus provides at least short-term protection from re-infection”, she added.
US biotech agency Moderna introduced this week its vaccine candidate was almost 95 p.c efficient in a trial — every week after comparable outcomes have been introduced by pharma big Pfizer and its German companion BioNTech.
The World Health Organization (WHO) welcomed the examine saying the findings prolonged its understanding of coronavirus safety.
“We really commend the researchers for doing those studies,” WHO emergencies director Michael Ryan informed reporters in Geneva, explaining the findings had delivered the “best data”.
Ryan added the antibody response detailed within the analysis gave “hope for longer periods of protection” from vaccine candidates.
The Oxford examine into reinfection drew on information from common coronavirus testing of 12,180 well being care employees at OUH over a interval of 30 weeks.
It discovered that not one of the 1,246 workers with coronavirus antibodies developed a symptomatic an infection.
Three members of workers with antibodies did check optimistic for the virus that causes Covid-19 however have been all properly and didn’t develop signs.
The WHO stated it’s working with 50 international locations the place research on antibody responses in numerous teams, akin to within the common inhabitants or amongst healthcare employees, have been going down.
The UN well being physique stated it was pooling these outcomes to provide a broader image of how the pandemic was growing.